GENFIT Stock OTC Markets
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
23:30:22 21/07/2026 +04
|
5-day change | 1st Jan Change | ||
| 15.95 USD | +48.37% |
|
-.--% | +165.83% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 694M 804M 653M 594M 1.12B 77.03B 1.13B 7.66B 3B 38.52B 3.02B 2.95B 128B | P/E 2026 * |
35.8x | P/E 2027 * | 92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 643M 745M 605M 550M 1.03B 71.35B 1.05B 7.1B 2.78B 35.69B 2.8B 2.74B 119B | EV / Sales 2026 * |
6.42x | EV / Sales 2027 * | 5.06x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +48.37% | ||
| 1 month | +48.37% | ||
| 3 months | +68.43% | ||
| 6 months | +98.63% | ||
| Current year | +165.83% |
| 1 month | 15.95 |  | 15.95 |
| Current year | 7.26 | | 15.95 |
| 1 year | 4.14 | | 15.95 |
| 3 years | 2.95 | | 15.95 |
| 5 years | 2.95 | | 15.95 |
| 10 years | 0 | | 36.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +48.37% | -.--% | - | - | 804M | |
| -0.11% | -1.67% | +1.80% | +19.90% | 48.84B | |
| +0.72% | +3.92% | +486.01% | +621.13% | 45.44B | |
| +1.45% | +2.36% | +15.16% | +90.49% | 41.22B | |
| +0.32% | -0.67% | +25.79% | +13.19% | 39.71B | |
| -2.74% | -2.74% | +17.30% | +56.10% | 32.6B | |
| +2.05% | -1.00% | - | - | 16.25B | |
| -1.43% | -2.47% | +27.57% | +136.52% | 16.67B | |
| -0.49% | -0.34% | +3.45% | +29.14% | 14.08B | |
| -1.50% | +0.21% | +80.01% | +42.07% | 13.68B | |
| Average | +4.65% | -0.78% | +82.14% | +126.07% | 29.83B | |
| Weighted average by Cap. | +0.11% | -0.84% | +103.03% | +152.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 116M 94.27M 85.68M 161M 11.12B 164M 1.11B 433M 5.56B 436M 426M 18.52B | 124M 144M 117M 106M 200M 13.76B 202M 1.37B 537M 6.88B 539M 528M 22.92B |
| Net income | 22.88M 26.49M 21.53M 19.56M 36.8M 2.54B 37.34M 252M 98.95M 1.27B 99.45M 97.29M 4.23B | 6.8M 7.87M 6.4M 5.81M 10.94M 754M 11.1M 75.05M 29.41M 377M 29.56M 28.92M 1.26B |
| Net Debt | -51.12M -59.18M -48.09M -43.71M -82.21M -5.67B -83.42M -564M -221M -2.84B -222M -217M -9.45B | -66.17M -76.62M -62.26M -56.59M -106M -7.34B -108M -730M -286M -3.67B -288M -281M -12.23B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- GNFTF Stock
Select your edition
All financial news and data tailored to specific country editions
